Chronic heart rate reduction by ivabradine prevents endothelial dysfunction in dyslipidaemic mice.

British Journal of Pharmacology
A DrouinJ-C Tardif

Abstract

High resting heart rate is a predictor for total and cardiovascular mortality independent of other risk factors in patients with coronary artery disease. We tested the hypothesis that a reduction of resting heart rate with the cardiac pacemaker I(f) current inhibitor ivabradine prevents the endothelial dysfunction associated with dyslipidaemia. Three-month-old dyslipidaemic (DL) male mice expressing the human ApoB-100 were assigned or not (DL, n=16), to treatment for 3 months with ivabradine (10 mg kg(-1) d(-1), n=17). Wild-type C57Bl/6 mice (WT, n=15) were used as controls. Heart rate was measured at 3, 4.5 and 6 months. Dilatation to acetylcholine (ACh) of isolated cerebral and renal arteries was investigated at 6 months. Heart rate remained stable in anaesthetized WT mice, increased (25%, P<0.05) with age in DL mice but was limited (11%, P<0.05) by ivabradine. At 6 months, left ventricular maximal pressure was similar in all groups. The minimal and end-diastolic left ventricular pressures were increased (P<0.05) in DL (10.2+/-1.0 and 18.7+/-1.4 mm Hg) compared to WT (-0.4+/-0.7 and 6.3+/-1.0 mm Hg) and reduced (P<0.05) by ivabradine (4.2+/-1.3 and 11.5+/-1.5 mm Hg). ACh-induced maximal dilatation was impaired (P<0.05) in ren...Continue Reading

References

May 1, 1991·Circulation Research·W B StrawnT B Clarkson
Jun 1, 1987·American Heart Journal·W B KannelL A Cupples
Apr 7, 2004·British Journal of Pharmacology·Xiao-Jun DuAnthony M Dart
Jul 1, 2004·Circulation·Vyacheslav A Korshunov, Bradford C Berk
Oct 11, 2005·European Heart Journal·Jean-Claude TardifUNKNOWN INITIATIVE Investigators
Apr 28, 2006·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·J P Vilaine
Sep 19, 2006·American Journal of Physiology. Heart and Circulatory Physiology·Marie-Eve GendronEric Thorin
Jun 29, 2007·Journal of Molecular and Cellular Cardiology·Judith BrouilletteCéline Fiset
Jul 17, 2007·Cellular Signalling·Michele CiccarelliGuido Iaccarino

❮ Previous
Next ❯

Citations

Aug 31, 2010·Lancet·John R Teerlink
Jul 10, 2009·Cardiovascular Research·Eric Thorin, Nathalie Thorin-Trescases
Dec 28, 2010·American Journal of Physiology. Heart and Circulatory Physiology·Annick DrouinEric Thorin
Sep 20, 2011·American Journal of Physiology. Heart and Circulatory Physiology·Virginie BolducEric Thorin
Jun 21, 2011·American Journal of Physiology. Heart and Circulatory Physiology·Roselle GélinasChristine Des Rosiers
Apr 29, 2011·World Journal of Cardiology·Alberto Dominguez-RodriguezPedro Abreu-Gonzalez
Jan 25, 2011·Expert Opinion on Pharmacotherapy·Graziano Riccioni
Jul 5, 2012·Journal of Vascular Research·Florian CustodisUlrich Laufs
Feb 8, 2014·European Journal of Heart Failure·Adriaan A VoorsUNKNOWN SHIFT investigators
Feb 6, 2017·Circulation Research·Xiaoming HuFrank M Faraci
May 15, 2013·Circulation·François Roubille, Jean-Claude Tardif
May 2, 2012·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Lorenza SperanzaGraziano Riccioni
Jan 24, 2009·Advances in Therapy·Graziano RiccioniNicolantonio D'Orazio
Jan 9, 2009·Journal of Cardiovascular Pharmacology·Nadir UluWiek H van Gilst
Mar 20, 2009·Current Opinion in Anaesthesiology·James D Hannon, Philippe R Housmans
Apr 27, 2010·Advances in Therapy·Graziano Riccioni
Feb 13, 2009·Expert Review of Cardiovascular Therapy·Graziano Riccioni
Sep 3, 2010·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Jan-Christian ReilMichael Böhm
Sep 1, 2011·Expert Review of Cardiovascular Therapy·Roberto Ferrari, Claudio Ceconi
Apr 11, 2012·International Journal of Cancer. Journal International Du Cancer·Chenming MaWolfgang Kemmner
Feb 19, 2014·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Ulrich Fischer-RasokatIoakim Spyridopoulos
Apr 4, 2015·Cardiology in Review·James J NawarskasJoe R Anderson
Dec 22, 2015·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Ulrich Fischer-RasokatChristian W Hamm
Aug 9, 2016·American Journal of Physiology. Heart and Circulatory Physiology·Fanny VaillantChristine Des Rosiers
Apr 5, 2016·Drugs·Gerd Heusch, Petra Kleinbongard
Oct 30, 2016·Anesthesiology·Marcos L MirandaEliete Bouskela
Mar 14, 2013·Menopause : the Journal of the North American Menopause Society·Jordi MerinoLluís Masana
Feb 24, 2015·Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research·Gokay NarAtilla Icli
Nov 26, 2010·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Neeraj Parakh, Balram Bhargava
Jul 28, 2009·British Journal of Pharmacology·J C McGrath
Aug 16, 2016·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Fabio MangiacapraGermano Di Sciascio
Aug 6, 2020·Frontiers in Medicine·Peter StankoFedor Simko
Jul 30, 2015·Journal of Cardiovascular Pharmacology·Nassiba MerabetPaul Mulder

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.